Target intelligence / Profile preview

G protein-coupled receptor 87 (GPR87)

Target
GPR87
Molecular classification
G protein-coupled receptor, Rhodopsin-like receptor (class A/1 GPCR), 7 transmembrane (7TM) receptor
01

Overview

G protein-coupled receptor 87 (GPR87) is an orphan member of the rhodopsin-like (class A) GPCR superfamily, located on human chromosome 3q25. It is characterized by seven transmembrane domains, conserved motifs (such as the DRY motif), and has been identified as a receptor for lysophosphatidic acid (LPA). GPR87 is overexpressed in multiple cancer types, notably squamous cell carcinoma of the lung and bladder, and is essential for tumor cell survival, particularly under stress conditions mediated by p53. Its involvement in signal transduction, cell survival, and metabolic regulation underscores its promise as a therapeutic target in oncology. However, as an orphan receptor, its endogenous ligand was initially unknown and drug development is ongoing, with no approved antagonists or modulators yet.

Other names
GPR87GPR-87G-protein coupled receptor 87CxLT2-like receptor (rare)H963MGC129731
02

Mechanism of action

Approaches under investigation include: Antibody-based (mAb) inhibition of cell-surface GPCRs; Small molecule antagonists or inverse agonists blocking signal transduction; RNAi/gene knockdown or gene editing for target inactivation.

03

Biological functions

Signal transductionModulation of cell survival (particularly p53/TP53-dependent survival in response to DNA damage)Regulation of Hippo-YAP signaling (affects glycolysis and oxidative stress by regulating hexokinase-2/HK2)Intracellular signal transductionCell proliferation
04

Disease associations

CancerSquamous cell carcinomaLung squamous cell carcinomaBladder carcinomaOvarian cancer progression
05

Safety considerations

Unknown, as clinical translation is pending.Potential off-tumor/on-target toxicity if expressed in non-cancerous tissueImpact of GPCR modulation on normal physiological signaling is a general challenge.
06

Biomarkers

Overexpression of GPR87 in tumor samples (especially squamous cell carcinomas) is used as a biomarker candidate for diagnosis, prognosis, and potential therapeutic selection

Beyond the preview

Go deeper on G protein-coupled receptor 87 (GPR87).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on G protein-coupled receptor 87 (GPR87).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call